Nu Skin Enterprises (NYSE:NUS) Posts Quarterly Earnings Results

Nu Skin Enterprises (NYSE:NUS) announced its quarterly earnings results on Wednesday. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72, Briefing.com reports. Nu Skin Enterprises had a net margin of 4.59% and a return on equity of 23.52%. The company had revenue of $583.36 million for the quarter, compared to analyst estimates of $582.49 million. During the same quarter last year, the business earned $1.05 earnings per share. Nu Skin Enterprises’s revenue was down 14.6% compared to the same quarter last year.

Shares of NYSE:NUS traded up $1.10 during trading on Friday, reaching $31.07. 24,746 shares of the company traded hands, compared to its average volume of 613,827. The firm has a fifty day simple moving average of $38.18 and a 200 day simple moving average of $40.32. The firm has a market cap of $1.96 billion, a P/E ratio of 15.29, a price-to-earnings-growth ratio of 1.14 and a beta of 0.78. Nu Skin Enterprises has a 1-year low of $29.09 and a 1-year high of $67.00. The company has a quick ratio of 1.24, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 11th. Investors of record on Friday, February 28th will be paid a $0.375 dividend. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.37. The ex-dividend date of this dividend is Thursday, February 27th. This represents a $1.50 dividend on an annualized basis and a yield of 4.83%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 42.05%.

NUS has been the topic of several recent research reports. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating and set a $44.00 price target on the stock. in a research report on Monday, November 11th. Citigroup decreased their price target on shares of Nu Skin Enterprises from $43.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday. Stifel Nicolaus upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and lifted their price target for the stock from $38.50 to $45.00 in a research report on Tuesday, October 29th. Bank of America decreased their price target on shares of Nu Skin Enterprises from $40.00 to $30.00 and set an “underperform” rating on the stock in a research report on Thursday. Finally, DA Davidson restated an “in-line” rating and issued a $35.00 price target on shares of Nu Skin Enterprises in a research report on Thursday. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $44.63.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Further Reading: What is FinTech?

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.